Nu Skin Enterprises (NYSE:NUS – Get Rating) had its price objective lowered by equities researchers at DA Davidson from $40.00 to $34.00 in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage currently has a “neutral” rating on the stock. DA Davidson’s price objective points to a potential downside of 11.78% from the company’s previous close. DA Davidson also issued estimates for Nu Skin Enterprises’ Q4 2022 earnings at $0.50 EPS.
A number of other research analysts have also weighed in on the company. Citigroup reduced their target price on Nu Skin Enterprises from $39.00 to $35.00 in a report on Friday, November 4th. TheStreet lowered Nu Skin Enterprises from a “b” rating to a “c” rating in a report on Thursday, August 4th. Finally, StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, November 4th.
Nu Skin Enterprises Stock Down 1.1 %
NUS stock opened at $38.54 on Wednesday. The company has a quick ratio of 1.23, a current ratio of 2.13 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $1.90 billion, a PE ratio of 52.08 and a beta of 1.22. Nu Skin Enterprises has a twelve month low of $29.95 and a twelve month high of $56.76. The stock has a 50-day simple moving average of $36.65 and a two-hundred day simple moving average of $41.32.
Insider Transactions at Nu Skin Enterprises
Institutional Trading of Nu Skin Enterprises
Several hedge funds and other institutional investors have recently bought and sold shares of the company. State Street Corp boosted its stake in Nu Skin Enterprises by 3.3% in the third quarter. State Street Corp now owns 9,466,774 shares of the company’s stock worth $315,906,000 after buying an additional 305,539 shares in the last quarter. BlackRock Inc. lifted its position in Nu Skin Enterprises by 0.5% in the first quarter. BlackRock Inc. now owns 5,791,181 shares of the company’s stock valued at $277,281,000 after purchasing an additional 30,340 shares during the last quarter. Renaissance Technologies LLC lifted its position in Nu Skin Enterprises by 5.6% in the second quarter. Renaissance Technologies LLC now owns 2,819,396 shares of the company’s stock valued at $122,080,000 after purchasing an additional 148,400 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Nu Skin Enterprises by 8.4% in the third quarter. Dimensional Fund Advisors LP now owns 1,915,864 shares of the company’s stock valued at $63,935,000 after purchasing an additional 147,865 shares during the last quarter. Finally, AQR Capital Management LLC lifted its position in Nu Skin Enterprises by 19.9% in the second quarter. AQR Capital Management LLC now owns 849,131 shares of the company’s stock valued at $36,521,000 after purchasing an additional 140,932 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
- Get a free copy of the StockNews.com research report on Nu Skin Enterprises (NUS)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.